Prepared for:

Agency for Healthcare Research and Quality

U.S. Department of Health and Human Services

540 Gaither Road

Rockville, MD 20850

www.ahrq.gov

Contract No. 290-02-0020

Prepared by:

McMaster University Evidence-based Practice Center

Hamilton, Ontario, Canada

Task Order Leaders:

Mark Oremus, Ph.D.

Mark Hanson, M.D., M.Ed., F.R.C.P.C.

Authors:

Mark Oremus, Ph.D.

Mark Hanson, M.D., M.Ed., F.R.C.P.C.

Richard Whitlock, M.D., M.Sc.

Ed Young, Ph.D.

Alok Gupta, M.S.

Arianna Dal Cin, M.D., B.Sc., F.R.C.S.C.

Carolyn Archer, M.Sc.

Parminder Raina, Ph.D.

AHRQ Publication No. 07-E004

December 2006

This document is in the public domain and may be used and reprinted without permission except those copyrighted materials noted for which further reproduction is prohibited without the specific permission of copyright holders.

Suggested Citation:

Oremus M, Hanson M, Whitlock R, Young E, Gupta A, Dal Cin A, Archer C, Raina P. The Uses of Heparin To Treat Burn Injury. Evidence Report/Technology Assessment No. 148. (Prepared by the McMaster University Evidence-based Practice Center, under Contract No. 290-02-0020). AHRQ Publication No. 07-E004. Rockville, MD: Agency for Healthcare Research and Quality. December 2006.

This report is based on research conducted by the McMaster University Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-02-0020). The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessarily represent the views of AHRQ. No statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services.

The information in this report is intended to help clinicians, employers, policymakers, and others make informed decisions about the provision of health care services. This report is intended as a reference and not as a substitute for clinical judgment.

This report may be used, in whole or in part, as the basis for the development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.

Dr. Young is affiliated with the Henderson Research Center, which has interests in Heparin. Drs. Oremus, Hanson, Whitlock, Gupta, Dal Cin, and Raina have no financial interest in this field, nor does Ms. Archer.